NCT00326378View on ClinicalTrials.gov

Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

434

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

March 31, 2013

Study Completion Date

May 31, 2015

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

consolidation chemotherapy with Docetaxel plus cisplatin

definitive CCRT, and followed by consolidation chemotherapy with three cycles of docetaxel plus cisplatin

DRUG

CCRT arm without consolidation chemotherapy

definitive CCRT with weekly Docetaxel/CDDP #6 without consolidation chemotherapy

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Samsung Medical Center

OTHER